17-7445183-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_000747.3(CHRNB1):c.56C>A(p.Pro19Gln) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000559 in 1,610,544 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000747.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHRNB1 | ENST00000306071.7 | c.56C>A | p.Pro19Gln | missense_variant, splice_region_variant | 1/11 | 1 | NM_000747.3 | ENSP00000304290.2 | ||
ENSG00000272884 | ENST00000575331.1 | n.4770C>A | non_coding_transcript_exon_variant | 3/3 | 1 | |||||
CHRNB1 | ENST00000572857.5 | c.56C>A | p.Pro19Gln | missense_variant, splice_region_variant | 1/6 | 4 | ENSP00000461402.1 | |||
CHRNB1 | ENST00000574054.1 | n.76C>A | splice_region_variant, non_coding_transcript_exon_variant | 1/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152164Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000850 AC: 2AN: 235276Hom.: 0 AF XY: 0.0000154 AC XY: 2AN XY: 129730
GnomAD4 exome AF: 0.00000480 AC: 7AN: 1458380Hom.: 0 Cov.: 31 AF XY: 0.00000551 AC XY: 4AN XY: 725506
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152164Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74340
ClinVar
Submissions by phenotype
Congenital myasthenic syndrome 2A Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 27, 2022 | This sequence change replaces proline, which is neutral and non-polar, with glutamine, which is neutral and polar, at codon 19 of the CHRNB1 protein (p.Pro19Gln). This variant is present in population databases (rs759176796, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with CHRNB1-related conditions. ClinVar contains an entry for this variant (Variation ID: 1506790). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Not Available"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at